It is not too late to achieve global covid-19 vaccine equity

Abstract

During the covid-19 pandemic, we have seen the best of international collective action and its limits. Global scientific cooperation drove the development of safe, highly effective covid-19 vaccines in under one year. 1 Yet we have also witnessed global vaccine inequity, 2 in which low and middle income countries have "limited supply and limited vaccine brand options." 3 With the omicron wave dissipating, several well vaccinated high income nations with stockpiles of covid-19 vaccines are rushing to declare the pandemic over, reminding us of how things unfolded with tuberculosis, malaria, and HIV/AIDS in the past. But the pandemic is not over and 2.8 billion people remain completely unvaccinated. Now is the time to recommit to, and further invest in, equitable and effective country led vaccination campaigns.